The fall from grace of Dr. Daniel Chan Pai Sheng and Dr. Michael Tan Kim Song, the co-founders of the prominent healthcare provider Fullerton Health, serves as a sobering reminder of how easily professional integrity can be compromised within the upper echelons of corporate leadership. On July 10, the two men—both 52—faced a courtroom to answer for their roles in a scheme involving the falsification of entertainment expense claims. While they ultimately walked away without prison time, the legal proceedings shed light on a troubling breakdown of corporate governance. The duo managed to avoid the more severe charge of bribery through a legal discharge, yet the fines imposed—S$135,000 for Dr. Chan and S$25,000 for Dr. Tan—mark the end of a long-standing investigation that once implicated other high-ranking associates, including the former CEO of Aon Singapore.
The mechanics of the fraud were rooted in an unsettling degree of internal autonomy. As senior leaders, Dr. Chan and Dr. Tan possessed the authority to approve their own business expenses, effectively bypassing the scrutiny of their finance team. The judge presiding over the case aptly described this as a system that “effectively checked itself,” creating an environment where the absence of independent oversight provided the perfect cover for their activities. What began as a series of professional maneuvers evolved into a calculated effort to funnel company money through inflated receipts. Because the finance department was kept at arm’s length, these illicit transactions remained shielded from detection for a significant period, highlighting a systemic vulnerability in the company’s internal controls.
The motivation behind these falsifications was not personal enrichment in the traditional sense, but rather a misguided desire to provide financial assistance to a third party, Collin Chiew, the former CEO of Aon Singapore. Court documents reveal that Chiew had approached Dr. Chan, citing severe personal financial pressures related to housing and his children’s needs. In a lapse of judgment that ultimately derailed their careers, the two co-founders decided to support him by padding expense claims. Dr. Chan would secure inflated receipts from colleagues overseas—specifically from the managing director of Fullerton Health China—and submit them as legitimate business travel costs. It was a conspiracy born of professional proximity that blurred the lines between benevolence and criminality.
Dr. Chan, who served as the deputy group CEO, bore the brunt of the legal consequences for his more direct role in orchestrating the scheme. The court found that he was not merely following orders but was an active participant who understood the gravity of submitting falsified records. With his offenses involving over S$253,000 in claims, District Judge Paul Quan did not mince words regarding the severity of his actions, noting that they were “by no means insubstantial.” His defense team’s attempt to characterize him as a subordinate acting under the influence of others was rejected, as the judge emphasized that the fraudulent claims could never have materialized without his active submission of the falsified documentation.
Dr. Tan, acting as the group CEO, faced a different, though no less significant, burden of responsibility. While his legal team sought to paint his participation as a one-off error in judgment—an out-of-character lapse in his executive duties—the court disagreed. By knowingly approving claims that he understood to be inflated to benefit Chiew, Dr. Tan violated the foundational trust placed in him by the company. His role, while perhaps more passive than Dr. Chan’s, was the final gatekeeper of the fraud. The judge’s sentencing was a clear message that leadership requires more than just the authority to sign off on expenses; it requires the moral clarity to identify and reject actions that compromise the company’s financial integrity.
Ultimately, this saga highlights how even those who reach the pinnacle of their professions are not immune to the pressures of corporate “cronyism.” By attempting to solve a friend’s financial problems with company resources, these two men jeopardized both their reputations and the standard of governance at Fullerton Health. While they avoided the harshest of penalties, the legal outcome serves as a permanent stain on their legacies. As the case shifts toward the trial of Collin Chiew, the individuals involved are left to contend with the reality that their efforts to assist a colleague in need became the catalyst for their own downfall, proving that in business, there is no shortcut to helping others that doesn’t eventually demand a heavy price.